Bulletin
Investor Alert

New York Markets Open in:

Vifor Pharma AG

SWX: CH:VIFN

GO

/zigman2/quotes/205554886/delayed

CHF

178.95

Change

+1.15 +0.65%

Volume

Volume 562

May 18, 2022, 9:27 a.m.

Quotes are delayed by 20 min

/zigman2/quotes/205554886/delayed

Previous close

CHF 177.80

CHF 178.95

Change

+1.15 +0.65%

Day low

Day high

CHF177.80

CHF179.50

Open
Open: 177.80

52 week low

52 week high

CHF102.30

CHF180.05

Open

Market cap

CHF11.61B

Average volume

146,313

P/E ratio

80.67

Rev. per Employee

CHF711,066

EPS

2.22

Dividend

2.00

Div yield

1.12%

Ex dividend date

4/29/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/ch/vifn

MarketWatch News on VIFN

/news/nonmarketwatch/company/ch/vifn

Other News on VIFN

No News currently available for VIFN

/news/pressrelease/company/ch/vifn

Press Releases on VIFN

  1. Update on the timeline for Vifor Pharma tender offer

    9:21 a.m. May 12, 2022

    - BusinessWire - BZX

  2. 94th Vifor Pharma Group Annual General Meeting

    11:45 a.m. April 26, 2022

    - BusinessWire - BZX

  3. Publication of definitive end result for Vifor Pharma tender offer

    1:00 a.m. March 28, 2022

    - BusinessWire - BZX

  4. Vifor Pharma reports sustained growth in 2021

    2:00 a.m. Feb. 17, 2022

    - BusinessWire - BZX

  5. Vifor Pharma appoints two new members to the Executive Committee

    2:00 a.m. Feb. 2, 2022

    - BusinessWire - BZX

  6. CSL Limited announces tender offer to acquire Vifor Pharma Ltd

    1:44 a.m. Dec. 14, 2021

    - BusinessWire - BZX

  7. Vifor Pharma comments on media speculation

    3:59 a.m. Dec. 13, 2021

    - BusinessWire - BZX

  8. Vifor Pharma comments on market speculations

    1:40 p.m. Dec. 2, 2021

    - BusinessWire - BZX

  9. Loading more headlines...

Rates »

Link to MarketWatch's Slice.